Search

Speech

599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

Carrasco, Javier Beniuga, Gabriela[UCL] Mourin, Anne[UCL] Baldin, Paméla[UCL] Sinapi, Isabelle Schroeder, David De Cuyper, Astrid[UCL] Sclafani, Francesco Hendlisz, Alain van Laethem, Jean-Luc Boulanger, Anne-Sophie Van Ooteghem, Geneviève[UCL] Dermine, Alexandre Delmarcelle, Sophie Huyghe, Nicolas[UCL] Bar, Isabelle Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid

Speech

Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.

Van den Eynde, Marc[UCL] Huyghe, Nicolas De Cuyper, Astrid[UCL] Sinapi, Isabelle Ferrier, Marie Gilet, Mélanie Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerome Carrasco, Javier (2021) 2021 Gastrointestinal Cancers Symposium —

Journal article

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric study.

Livin, Marie[UCL] Léonard, Daniel[UCL] Bachmann, Radu[UCL] Remue, Christophe[UCL] Barbois, Sandrine[UCL] Cotte, Eddy Van den Eynde, Marc[UCL] De Cuyper, Astrid[UCL] Sinapi, Isabelle[UCL] Van Maanen, Aline[UCL] Kartheuser, Alex[UCL] (2022) Acta gastro-enterologica Belgica — Vol. 85, no. 4, p. 573-579 (2022)

Speech

635P Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study

Van den Eynde, Marc[UCL] Huyghe, Nicolas[UCL] Sinapi, Isabelle De Cuyper, Astrid[UCL] Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, Matthias Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerôme Carrasco, Javier (2023) ESMO Congress 2023 — (Spain) Madrid

Speech

Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

Huyghe, Nicolas[UCL] De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Rehaman Rinchai, Darawan Beyaert, Simon[UCL] Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Gilet, Mélanie Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Mlecnik, Bernhard Carrasco, Javier Galon, Jerome Bedognetti, Davide Van den Eynde, Marc[UCL] (2022) 2022 ASCO Annual Meeting I —

Journal article

Fibrose retropéritoneale et myelome multiple : association fortuite ?

Sinapi, Isabelle[UCL] Caers, J. Connerotte, Thierry[UCL] Koutaissoff, S. Lambert, Marie-Thérèse[UCL] (2010) La Revue de médecine interne / fondée par la Société nationale française de médecine interne — Vol. 31, no. 5, p. e4-6 (2010)

Speech

2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial

Huyghe, Nicolas[UCL] Benidovskaya, Elena[UCL] Masoodi, Tariq Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, M. Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jérôme Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid

Speech

Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

Baldin, Paméla[UCL] Beniuga, Gabriella Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Hubert, Catherine[UCL] Navez, Benoît[UCL] Castella, Marie-Laure Van Maanen, Aline[UCL] Mlecnik, Bernhard Galon, Jerome Jouret-Mourin, Anna[UCL] Van den Eynde, Marc[UCL] (2022) 2022 ASCO Annual Meeting I —

Journal article

Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report.

Baudon, Céline[UCL] Duhoux, François[UCL] Sinapi, Isabelle Canon, Jean-Luc (2016) Journal of Medical Case Reports — Vol. 10, no.1, p. 178 (2016)

Journal article

Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial)

Baldin, Paméla[UCL] Carrasco, Javier Beniuga, Gabriela Mourin, Anne[UCL] Demolin, Gauthier Roland, Sandrine D'Hondt, Lionel[UCL] Vergauwe, Philippe Van Daele, Daniel Mailleux, Marie Sinapi, Isabelle De Cuyper, Astrid[UCL] Blétard, Noëlla Massart, Brigitte Delos, Monique[UCL] Castella, Marie-Laure[UCL] van Maanen, Aline[UCL] Van den Eynde, Marc[UCL] (2022) Cancers — Vol. 14, no. 5, p. 1183 [1-16] (2022)

Journal article

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

van Marcke, Cédric[UCL] Honoré, Natasha[UCL] van der Elst, Athénaïs[UCL] Beyaert, Simon[UCL] Derouane, Françoise[UCL] Dumont, Caroline[UCL] Aboubakar Nana, Frank[UCL] Baurain, Jean-François[UCL] Borbath, Ivan[UCL] Collard, Philippe[UCL] Cornelis, Frank[UCL] De Cuyper, Astrid[UCL] Duhoux, Francois[UCL] Filleul, Bertrand Galot, Rachel[UCL] Gizzi, Marco[UCL] Mazzeo, Filomena[UCL] Pieters, Thierry[UCL] Seront, Emmanuel[UCL] Sinapi, Isabelle[UCL] Van Den Eynde, Marc[UCL] Whenham, Nicolas Yombi, Jean Cyr[UCL] Scohy, Anaïs[UCL] van Maanen, Aline[UCL] Machiels, Jean-Pascal[UCL] (2021) BMC cancer — Vol. 21, no.1, p. 578 [1-12] (2021)

Journal article

Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: case report and review of the literature

Sinapi, Isabelle Navez, Benoît[UCL] Hamoir, Marc[UCL] Schmitz, Sandra[UCL] Machiels, Jean-Pascal[UCL] Deprez, Pierre Henri[UCL] Van Den Eynde, Marc[UCL] (2013) Head & Neck : journal for the sciences and specialities of the head and neck — Vol. 35, no.7, p. E209-E212 (2013)

Speech

120P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Characterization of the circulating immune response in the AVETUXIRI phase II trial

Benidovskaya, Elena[UCL] Huyghe, Nicolas[UCL] Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Verstraelen, Eléonore[UCL] Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, M. Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jérôme Van den Eynde, Marc[UCL] (2024) the ESMO Gastrointestinal Cancers Congress 2024 — (Germany) Munich

User menu

Author

Date

Document Type

Access

Footer Help

Languages

Footer menu